2015
DOI: 10.1016/j.cbi.2015.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Rosemary tea consumption results to anxiolytic- and anti-depressant-like behavior of adult male mice and inhibits all cerebral area and liver cholinesterase activity; phytochemical investigation and in silico studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
39
0
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(43 citation statements)
references
References 60 publications
2
39
0
2
Order By: Relevance
“…Similarly, Ozarowski et al . and Ferlemi et al . suggested that rosemary tea inhibits brain CHE activity, leading to improved long‐term memory in rats.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, Ozarowski et al . and Ferlemi et al . suggested that rosemary tea inhibits brain CHE activity, leading to improved long‐term memory in rats.…”
Section: Discussionmentioning
confidence: 99%
“…Phytochemical characterization in rosemary extracts has shown that the main bioactive compounds in rosemary are polyphenols. Extracted by supercritical fluid, microwave or infusion, the main phenolic compounds present in rosemary extracts are hesperidin, homoplantaginin, luteolin‐glucuronide, rosmarinic acid, rosmarinic acid‐3‐ O ‐glucoside, luteolin 3‐ O ‐( O ‐acetyl)‐ β ‐ d ‐glucuronide, cirsimaritin and rosmanol . A recent study characterized forty‐nine compounds in rosemary tea belonging to six families, namely flavonoids, phenolic acids, phenolic terpenes, jasmonate, phenolic glycosides and lignans, with rosmarinic acid being the main compound in addition to caffeic acid and luteolin derivatives, among others .…”
Section: Introductionmentioning
confidence: 99%
“…В экспериментах на животных показано, что розмарин повышает содержание ацетилхолина в ЦНС, уменьшает окислительное повреждение нейронов и реактивный астроцитоз в таких моделях, как экспериментальная болезнь Альцгеймера [Huegel H.M., 2015], экспериментальный ишемический инсульт [Seyedemadi P. et al, 2016], повторные черепно-мозговые травмы [Song H. et al, 2016], физиологическое возрастное когнитивное снижение [Pengelly A. et al, 2012]. Ряд компонентов розмарина, в частности розмариновая кислота, лютеолин-7-О-глюкуронид, кофейная кислота, являются ингибиторами ацетилхолинэстеразы и бутирилхолинэстеразы [Ferlemi A.V. et al, 2015].…”
Section: розмаринunclassified